April 9, 2018 / 7:21 AM / in 5 months

BRIEF-Pangaea Oncology Signs Strategic Deal In Oncological Diagnosis With Qiagen

April 9 (Reuters) - Pangaea Oncology SA:

* SAYS SIGNS STRATEGIC AGREEMENT IN ONCOLOGICAL DIAGNOSIS WITH GERMAN DIAGNOSTIC MULTINATIONAL QIAGEN

* SAYS DEAL HAS INITIAL DURATION OF THREE YEARS, EXTENDABLE ANNUALLY BY MUTUAL AGREEMENT

* AS FIRST STEP CO TO PERFORM QIAGEN TECHNOLOGY VALIDATION TASKS FOR DIAGNOSIS OF VARIOUS TUMOR TYPES

* THIS CONTRACT IS FOR AN AMOUNT OF 149,000 EUROS OVER A PERIOD OF SIX MONTHS Source text: bit.ly/2qiR1gq Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below